Health
COVID-19 vaccine study has a warning for people who take common IBD drug – SlashGear
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower…
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower than expected. The issue was observed in people taking an immune-suppressing drug called infliximab, which is commonly prescribed for IBD.
Vaccines, including the COVID-19 vaccine, work by triggering the patient’s own immune system, resulting in the development of antibodies that help protect the individual from an infection caused by…
-
Business18 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News17 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business13 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News16 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses